BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1383224)

  • 21. Intrasteric regulation of myosin light chain kinase: the pseudosubstrate prototope binds to the active site.
    Bagchi IC; Kemp BE; Means AR
    Mol Endocrinol; 1992 Apr; 6(4):621-6. PubMed ID: 1584224
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phosphorylation of calmodulin in the first calcium-binding pocket by myosin light chain kinase.
    Davis HW; Crimmins DL; Thoma RS; Garcia JG
    Arch Biochem Biophys; 1996 Aug; 332(1):101-9. PubMed ID: 8806714
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of Mg2+-binding sites and the role of Mg2+ on target recognition by calmodulin.
    Ohki S; Ikura M; Zhang M
    Biochemistry; 1997 Apr; 36(14):4309-16. PubMed ID: 9100027
    [TBL] [Abstract][Full Text] [Related]  

  • 24. AMP-activated protein kinase phosphorylates and desensitizes smooth muscle myosin light chain kinase.
    Horman S; Morel N; Vertommen D; Hussain N; Neumann D; Beauloye C; El Najjar N; Forcet C; Viollet B; Walsh MP; Hue L; Rider MH
    J Biol Chem; 2008 Jul; 283(27):18505-12. PubMed ID: 18426792
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Ca2+ -activated protease (calpain) modulates Ca2+/calmodulin dependent activity of smooth muscle myosin light chain kinase.
    Ito M; Tanaka T; Nunoki K; Hidaka H; Suzuki K
    Biochem Biophys Res Commun; 1987 Jun; 145(3):1321-8. PubMed ID: 3038096
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitative analysis of the free energy coupling in the system calmodulin, calcium, smooth muscle myosin light chain kinase.
    Mamar-Bachi A; Cox JA
    Cell Calcium; 1987 Dec; 8(6):473-82. PubMed ID: 3435915
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methionine to glutamine substitutions in the C-terminal domain of calmodulin impair the activation of three protein kinases.
    Chin D; Means AR
    J Biol Chem; 1996 Nov; 271(48):30465-71. PubMed ID: 8940012
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of the Ca2+ -dependent and -independent interactions between calmodulin and its binding domain of inducible nitric oxide synthase.
    Yuan T; Vogel HJ; Sutherland C; Walsh MP
    FEBS Lett; 1998 Jul; 431(2):210-4. PubMed ID: 9708904
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Calmodulin binding to myosin light chain kinase begins at substoichiometric Ca2+ concentrations: a small-angle scattering study of binding and conformational transitions.
    Krueger JK; Bishop NA; Blumenthal DK; Zhi G; Beckingham K; Stull JT; Trewhella J
    Biochemistry; 1998 Dec; 37(51):17810-7. PubMed ID: 9922147
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thyroid hormones directly interact with vascular smooth muscle strips.
    Ishikawa T; Chijiwa T; Hagiwara M; Mamiya S; Hidaka H
    Mol Pharmacol; 1989 Jun; 35(6):760-5. PubMed ID: 2733694
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The fourth EF-hand of calmodulin and its helix-loop-helix components: impact on calcium binding and enzyme activation.
    George SE; Su Z; Fan D; Wang S; Johnson JD
    Biochemistry; 1996 Jun; 35(25):8307-13. PubMed ID: 8679587
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of smooth muscle myosin light chain kinase by calmodulin. Role of LYS(30) and GLY(40).
    Van Lierop JE; Wilson DP; Davis JP; Tikunova S; Sutherland C; Walsh MP; Johnson JD
    J Biol Chem; 2002 Feb; 277(8):6550-8. PubMed ID: 11748245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myosin light chain kinase from vascular smooth muscle inhibits the ATP-dependent interaction between actin and myosin by binding to actin.
    Sato M; Ye LH; Kohama K
    J Biochem; 1995 Jul; 118(1):1-3. PubMed ID: 8537296
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of ruthenium red on activation of Ca2(+)-dependent cyclic nucleotide phosphodiesterase.
    Masuoka H; Ito M; Nakano T; Naka M; Tanaka T
    Biochem Biophys Res Commun; 1990 May; 169(1):315-22. PubMed ID: 1693502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of smooth-muscle myosin-light-chain phosphatase by Ruthenium Red.
    Yamada A; Sato O; Watanabe M; Walsh MP; Ogawa Y; Imaizumi Y
    Biochem J; 2000 Aug; 349 Pt 3(Pt 3):797-804. PubMed ID: 10903141
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of ruthenium red-binding sites of the Ca(2+)-ATPase from sarcoplasmic reticulum and their interaction with Ca(2+)-binding sites.
    Corbalan-Garcia S; Teruel JA; Gomez-Fernandez JC
    Biochem J; 1992 Nov; 287 ( Pt 3)(Pt 3):767-74. PubMed ID: 1280106
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ruthenium red and compound 48/80 inhibit the smooth-muscle plasma-membrane Ca2+ pump via interaction with associated polyphosphoinositides.
    Missiaen L; De Smedt H; Droogmans G; Wuytack F; Raeymaekers L; Casteels R
    Biochim Biophys Acta; 1990 Apr; 1023(3):449-54. PubMed ID: 1692244
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Calcium-dependent and -independent interactions of the calmodulin-binding domain of cyclic nucleotide phosphodiesterase with calmodulin.
    Yuan T; Walsh MP; Sutherland C; Fabian H; Vogel HJ
    Biochemistry; 1999 Feb; 38(5):1446-55. PubMed ID: 9931009
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterizing the response of calcium signal transducers to generated calcium transients.
    Davis JP; Tikunova SB; Walsh MP; Johnson JD
    Biochemistry; 1999 Mar; 38(13):4235-44. PubMed ID: 10194340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ca2+ sensitization of smooth muscle contractility induced by ruthenium red.
    Yamada A; Ohya S; Hirano M; Watanabe M; Walsh MP; Imaizumi Y
    Am J Physiol; 1999 Mar; 276(3):C566-75. PubMed ID: 10069983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.